MoneyWorks4Me

USFDA completes Inspection at Solara Active Pharma Science’s manufacturing facility

28 Jan 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at Solara Active Pharma Science’s manufacturing facility in Ambernath, in the state of Maharashtra with zero 483s inspectional observations. The company stays committed to demonstrating the highest level of compliance with yet another USFDA audit with ‘Zero 483s’.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1846.70
Dr. Reddys Labs. 1200.90
Cipla 1404.35
Lupin 2086.45
Zydus Lifesciences 1197.30
View more..